Thurston Springer Miller Herd & Titak’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,884
Closed -$91K 1240
2025
Q2
$91K Hold
1,884
0.01% 528
2025
Q1
$104K Buy
1,884
+1,711
+989% +$92.6K 0.02% 450
2024
Q4
$8.34K Hold
173
﹤0.01% 928
2024
Q3
$9.97K Hold
173
﹤0.01% 1034
2024
Q2
$8.39K Buy
+173
New +$8.35K ﹤0.01% 1079

Other funds holding SNY

Thurston Springer Miller Herd & Titak's SNY Position: Q3 2025 in Review

Thurston Springer Miller Herd & Titak sold out of Sanofi (SNY) in Q3 2025, closing a stake of 1,884 shares — an estimated $91K sold.

Thurston Springer Miller Herd & Titak first reported a position in SNY in Q2 2024 and held it in 5 quarters. The position peaked at $104K in Q1 2025. 710 funds tracked by Wall St. Rank hold SNY as of Q3 2025.

  • Thurston Springer Miller Herd & Titak reported no remaining Sanofi position as of Q3 2025 after selling out during the quarter.
  • Thurston Springer Miller Herd & Titak sold 1,884 Sanofi shares in Q3 2025, an estimated $91K.
  • Thurston Springer Miller Herd & Titak first reported a position in Sanofi in Q2 2024 and held it in 5 quarters.
  • Thurston Springer Miller Herd & Titak's Sanofi position peaked at $104K in Q1 2025.
  • 710 funds tracked by Wall St. Rank held Sanofi as of Q3 2025.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q3 2025, filed 7 Oct 2025.